Details for Patent: 8,069,851
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,069,851 protect, and when does it expire?
Patent 8,069,851 protects TOBI PODHALER and is included in one NDA.
This patent has sixteen patent family members in fourteen countries.
Summary for Patent: 8,069,851
Title: | Aeorosolization apparatus with air inlet shield |
Abstract: | An aerosolization apparatus comprises a housing defining a chamber having a plurality of air inlets. The chamber contains an aerosolizable pharmaceutical formulation or is sized to receive a receptacle which contains an aerosolizable pharmaceutical formulation. A shield covers at least one of the air inlets or a portion of at least one of the air inlets. The shield prevents blockage of the air inlet by a user grasping the apparatus and inadvertently covering the air inlet. An end section is associated with the housing. The end section is sized and shaped to be received in a user's mouth or nose so that the user may inhale through the end section to inhale aerosolized pharmaceutical formulation that has exited the receptacle. |
Inventor(s): | Dunkley; Michael John (Nottingham, GB), Tuckwell; Jon David (Cambridgeshire, GB), Vernon-Harcourt; Edward William (Cambridge, GB), Shirgoankar; Sameer (London, GB) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 12/456,807 |
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; Delivery; Device; |
Drugs Protected by US Patent 8,069,851
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,069,851
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 549051 | See Plans and Pricing | |||
Australia | 2004229446 | See Plans and Pricing | |||
Canada | 2520032 | See Plans and Pricing | |||
Cyprus | 1113859 | See Plans and Pricing | |||
Denmark | 1610850 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |